Generex Biotechnology Corp. (fka GNBTQ)

[RoswellChamp]

Generex says stated that the results of this Phase II Trial will be published later this year. You'll notice on the Trial website it says the final collection date for data was June 2013. That should mean they are compiling it now.

Assuming the results are favorable (and I have no reason to believe they will not be at this point) the trick is going to be to find a suitable partner for a Phase III Trial. Generex itself has neither the capital nor the resources to conduct such a Trial on its own.

I have always believed---suspected???---that one way to deal with that is to offer the potential partner a share of Antigen Express in return for the necessary funding and assistance. That could also be the way to start the path to a partial spin-off of Antigen Express, which they have stated they plan to do.

If all of this should occur, it would certainly mean a much higher price for the current shares of Generex.